Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cationic Albumin-Conjugated Chelating Agent As a Novel Brain Drug Delivery System in Neurodegeneration Publisher Pubmed



Kamalinia G1, 2, 3 ; Khodagholi F4 ; Shaerzadeh F4 ; Tavssolian F1 ; Chaharband F1 ; Atyabi F1, 2 ; Sharifzadeh M5 ; Amini M6 ; Dinarvand R1, 2
Authors

Source: Chemical Biology and Drug Design Published:2015


Abstract

The critical role of metal ions and in particular iron in oxidative stress and protein aggregation offers chelation therapy as a sensible pharmaceutical strategy in oxidative stress-induced neuronal damages. In this research, we conjugated an iron-chelating agent, deferasirox, to cationized human serum albumin molecules in order to develop a novel brain delivery system for the management of neurodegenerative disorders due to the significant role of oxidative stress-induced neuronal injury in such diseases. Cationized albumin is known to be able to transport to brain tissue via adsorptive-mediated transcytosis. The developed structures were molecularly characterized, and their conjugation ratio was determined. PC12 cell line was utilized to evaluate the neuroprotective features of these newly developed molecules in the presence of hydrogen peroxide neuronal damage and to identify the mechanisms behind the observed neuronal protection including apoptotic and autophagic pathways. Furthermore, a rat model of Alzheimer's disease was utilized to evaluate the impact of conjugated structures in vivo. Data analysis revealed that the conjugated species were able to hinder apoptotic cell death while enhancing autophagic process. The developed conjugated species were also able to attenuate amyloid beta-induced learning deficits when administered peripherally. This manuscript reports a novel cationized albumin-conjugated drug formulation followed by characterization and physicochemical evaluation, cell culture studies for evaluating any related neuroprotective effect as well as the residing molecular mechanisms behind it and an in vivo evaluation of its capability in attenuating Aβ-induced learning and memory deficits. We have demonstrated that cationized albumin-conjugated deferasirox can be exploited as a brain drug delivery system in neurodegenerative disorders by reducing apoptotic and enhancing autophagic pathways. © 2015 John Wiley & Sons A/S.
Other Related Docs
9. Nanoformulated Herbal Bioactives for the Treatment of Neurodegenerative Disorders, Herbal Bioactive-Based Drug Delivery Systems: Challenges and Opportunities (2022)
14. Simvastatin Enhances the Hippocampal Klotho in a Rat Model of Streptozotocin-Induced Cognitive Decline, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017)
18. Neuroprotective Agents in the Intensive Care Unit, Journal of Pharmacopuncture (2018)